A modified surgical technique to prevent rebleed in eye after vitreous removal surgery in diabetic retinal ( inner layer of eye) detachments .
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/12/060848
- Lead Sponsor
- Advanced Eye Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with type 2 diabetes who require vitrectomy for diabetic vitreous hemorrhage with TRD
Patients > 18yrs of age
Patients willing for preoperative injection of Ranibizumab (parent molecule or biosimilar)
Psuedophakic patients.
Patients willing for a follow up period of 3 months
Exclusion Criteria
Phakic and Aphakic patients
Patients with history of prior vitrectomy
Patients with combined retinal detachment
Patients with neovascular glaucoma and iris neovascularisation.
Eyes requiring internal tamponade in the event of intraoperative iatrogenic break formation will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method